-+ 0.00%
-+ 0.00%
-+ 0.00%

VAXART INC -VACCINE WAS SAFE AND WELL-TOLERATED AFTER NOROVIRUS CHALLENGE, WITH NO VACCINE-RELATED SERIOUS EVENTS

Reuters·05/14/2025 20:06:24

Please log in to view news